Increased tyrosine phosphorylation of focal adhesion proteins in myeloid cell lines expressing p210BCR/ABL
- PMID: 7566975
Increased tyrosine phosphorylation of focal adhesion proteins in myeloid cell lines expressing p210BCR/ABL
Abstract
The BCR/ABL oncogene causes chronic myelogenous leukemia (CML) in humans and induces growth factor independence of hematopoietic cell lines in tissue culture. p210BCR/ABL is localized at least in part to the cytoskeleton, and has been shown to interact directly with actin filaments through an actin binding domain located in the C-terminus of ABL. CML cells have reduced adhesion to some extracellular matrix components but the mechanism of this phenomenon is unknown. In this study we examined tyrosine phosphorylation of focal adhesion proteins in cells expressing p210BCR/ABL. An interleukin-3 (IL-3)-dependent cell line, 32Dc13, was transformed with a BCR/ABL cDNA, and the patterns of localization, expression, and tyrosine phosphorylation of focal adhesion proteins were compared among untransformed 32Dc13 cells with and without IL-3 stimulation and BCR/ABL-transformed 32Dc13 cells. Of the focal adhesion proteins examined, only paxillin exhibited tyrosine phosphorylation in response to IL-3; while in cells transformed by p210BCR/ABL, paxillin, vinculin, p125FAK, talin and tensin were constitutively tyrosine phosphorylated. IL-3 induced a transient association between paxillin and vinculin, while in BCR/ABL-transformed cells, several proteins coimmunoprecipitated with paxillin, including vinculin, p125FAK, talin and tensin. Pseudopodia enriched in focal adhesion proteins were transiently detected in 32Dc13 cells in response to IL-3, but constitutively detected in cells expressing p210BCR/ABL. p210BCR/ABL protein was also found concentrated in punctate structures adjacent to the cell membrane in myeloid cell lines, which often contained vinculin and paxillin.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
p210BCR/ABL induces formation of complexes containing focal adhesion proteins and the protooncogene product p120c-Cbl.Exp Hematol. 1996 Feb;24(2):310-3. Exp Hematol. 1996. PMID: 8641358
-
Tyrosine phosphorylation and activation of focal adhesion kinase (p125FAK) by BCR-ABL oncoprotein.Exp Hematol. 1995 Oct;23(11):1153-9. Exp Hematol. 1995. PMID: 7556524
-
Molecular cloning of human paxillin, a focal adhesion protein phosphorylated by P210BCR/ABL.J Biol Chem. 1995 Mar 10;270(10):5039-47. doi: 10.1074/jbc.270.10.5039. J Biol Chem. 1995. PMID: 7534286
-
Convergent signalling in the action of integrins, neuropeptides, growth factors and oncogenes.Cancer Surv. 1995;24:81-96. Cancer Surv. 1995. PMID: 7553664 Review.
-
New understanding of the pathogenesis of CML: a prototype of early neoplasia.Leukemia. 1997 Sep;11(9):1404-28. doi: 10.1038/sj.leu.2400751. Leukemia. 1997. PMID: 9305592 Review.
Cited by
-
TNS1: Emerging Insights into Its Domain Function, Biological Roles, and Tumors.Biology (Basel). 2022 Oct 26;11(11):1571. doi: 10.3390/biology11111571. Biology (Basel). 2022. PMID: 36358270 Free PMC article. Review.
-
Altered Ca2+ homeostasis in polymorphonuclear leukocytes from chronic myeloid leukaemia patients.Mol Cancer. 2006 Nov 27;5:65. doi: 10.1186/1476-4598-5-65. Mol Cancer. 2006. PMID: 17129370 Free PMC article.
-
RhoA: a therapeutic target for chronic myeloid leukemia.Mol Cancer. 2012 Mar 25;11:16. doi: 10.1186/1476-4598-11-16. Mol Cancer. 2012. PMID: 22443473 Free PMC article.
-
Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90.Nat Chem Biol. 2011 Sep 25;7(11):818-26. doi: 10.1038/nchembio.670. Nat Chem Biol. 2011. PMID: 21946277 Free PMC article.
-
Chronic myeloid leukemia stem cells in the era of targeted therapies: resistance, persistence and long-term dormancy.Oncotarget. 2011 Sep;2(9):713-27. doi: 10.18632/oncotarget.333. Oncotarget. 2011. PMID: 21946665 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Miscellaneous